Literature DB >> 18975951

Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation.

Eugénie Carletti1, He Li, Bin Li, Fredrik Ekström, Yvain Nicolet, Mélanie Loiodice, Emilie Gillon, Marie T Froment, Oksana Lockridge, Lawrence M Schopfer, Patrick Masson, Florian Nachon.   

Abstract

Human butyrylcholinesterase (hBChE) hydrolyzes or scavenges a wide range of toxic esters, including heroin, cocaine, carbamate pesticides, organophosphorus pesticides, and nerve agents. Organophosphates (OPs) exert their acute toxicity through inhibition of acetylcholinesterase (AChE) by phosphorylation of the catalytic serine. Phosphylated cholinesterase (ChE) can undergo a spontaneous, time-dependent process called "aging", during which the OP-ChE conjugate is dealkylated. This leads to irreversible inhibition of the enzyme. The inhibition of ChEs by tabun and the subsequent aging reaction are of particular interest, because tabun-ChE conjugates display an extraordinary resistance toward most current oxime reactivators. We investigated the structural basis of oxime resistance for phosphoramidated ChE conjugates by determining the crystal structures of the non-aged and aged forms of hBChE inhibited by tabun, and by updating the refinement of non-aged and aged tabun-inhibited mouse AChE (mAChE). Structures for non-aged and aged tabun-hBChE were refined to 2.3 and 2.1 A, respectively. The refined structures of aged ChE conjugates clearly show that the aging reaction proceeds through O-dealkylation of the P(R) enantiomer of tabun. After dealkylation, the negatively charged oxygen forms a strong salt bridge with protonated His438N epsilon2 that prevents reactivation. Mass spectrometric analysis of the aged tabun-inhibited hBChE showed that both the dimethylamine and ethoxy side chains were missing from the phosphorus. Loss of the ethoxy is consistent with the crystallography results. Loss of the dimethylamine is consistent with acid-catalyzed deamidation during the preparation of the aged adduct for mass spectrometry. The reported 3D data will help in the design of new oximes capable of reactivating tabun-ChE conjugates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18975951     DOI: 10.1021/ja804941z

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  33 in total

1.  Exposure to tri-o-cresyl phosphate detected in jet airplane passengers.

Authors:  Mariya Liyasova; Bin Li; Lawrence M Schopfer; Florian Nachon; Patrick Masson; Clement E Furlong; Oksana Lockridge
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-24       Impact factor: 4.219

2.  The inhibition, reactivation and mechanism of VX-, sarin-, fluoro-VX and fluoro-sarin surrogates following their interaction with HuAChE and HuBuChE.

Authors:  Chih-Kai Chao; Narayanaganesh Balasubramanian; John M Gerdes; Charles M Thompson
Journal:  Chem Biol Interact       Date:  2018-06-18       Impact factor: 5.192

3.  Profiling cholinesterase adduction: a high-throughput prioritization method for organophosphate exposure samples.

Authors:  Melissa D Carter; Brian S Crow; Brooke G Pantazides; Caroline M Watson; B Rey DeCastro; Jerry D Thomas; Thomas A Blake; Rudolph C Johnson
Journal:  J Biomol Screen       Date:  2013-08-16

4.  Why does the G117H mutation considerably improve the activity of human butyrylcholinesterase against sarin? Insights from quantum mechanical/molecular mechanical free energy calculations.

Authors:  Yuan Yao; Junjun Liu; Chang-Guo Zhan
Journal:  Biochemistry       Date:  2012-10-23       Impact factor: 3.162

Review 5.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

6.  A high-throughput UHPLC-MS/MS method for the quantification of five aged butyrylcholinesterase biomarkers from human exposure to organophosphorus nerve agents.

Authors:  Leigh Ann Graham; Darryl Johnson; Melissa D Carter; Emily G Stout; Huseyin A Erol; Samantha L Isenberg; Thomas P Mathews; Jerry D Thomas; Rudolph C Johnson
Journal:  Biomed Chromatogr       Date:  2016-10-09       Impact factor: 1.902

7.  Crystal structures of brain group-VIII phospholipase A2 in nonaged complexes with the organophosphorus nerve agents soman and sarin.

Authors:  Todd M Epstein; Uttamkumar Samanta; Stephen D Kirby; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

8.  Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.

Authors:  Cynthia Gilley; Mary MacDonald; Florian Nachon; Lawrence M Schopfer; Jun Zhang; John R Cashman; Oksana Lockridge
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

9.  Mass spectrometry method to identify aging pathways of Sp- and Rp-tabun adducts on human butyrylcholinesterase based on the acid labile P-N bond.

Authors:  Wei Jiang; John R Cashman; Florian Nachon; Patrick Masson; Lawrence M Schopfer; Oksana Lockridge
Journal:  Toxicol Sci       Date:  2013-01-23       Impact factor: 4.849

10.  Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes.

Authors:  Uttamkumar Samanta; Stephen D Kirby; Prabhavathi Srinivasan; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochem Pharmacol       Date:  2009-04-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.